Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Summary

The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in children and adolescents aged 6\~18 years with chronic tic disorders or Tourette's disorder

Timeline

Start

2008-10

Primary completion

2010-04

Completion

2010-04

Outcome

Met primary endpoint

paper compared to those who received placebo (-15.0 [8.4] and -9.6 [8.8], respectively, P=.0196). PMID 24021518 ↗

Publications

• Yoo HK, Joung YS, Lee JS, Song DH, Lee YS, Kim JW, Kim BN, Cho SC. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder. J Clin Psychiatry. 2013 Aug;74(8):e772-80. doi: 10.4088/JCP.12m08189.

Drugs

Indications